Skip to main content
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.17
-0.04 (-0.77%)
At close: Apr 28, 2026, 4:00 PM EDT
5.17
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Foghorn Therapeutics Revenue

In the year 2025, Foghorn Therapeutics had annual revenue of $30.91M with 36.75% growth. Foghorn Therapeutics had revenue of $9.25M in the quarter ending December 31, 2025, with 223.77% growth.

Revenue (ttm)
$30.91M
Revenue Growth
+36.75%
P/S Ratio
9.84
Revenue / Employee
$291,594
Employees
106
Market Cap
303.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202530.91M8.31M36.75%
Dec 31, 202422.60M-11.55M-33.83%
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cellectis 79.59M
Zentalis Pharmaceuticals 26.87M
LENZ Therapeutics 19.09M
Abeona Therapeutics 5.82M
Compass Therapeutics 850.00K
Inhibikase Therapeutics 1.00
Revenue Rankings

FHTX News

More News